Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun 19;5(8):976-981.
doi: 10.1002/acn3.594. eCollection 2018 Aug.

Olfactory dysfunction in amyotrophic lateral sclerosis

Affiliations

Olfactory dysfunction in amyotrophic lateral sclerosis

Cristina Viguera et al. Ann Clin Transl Neurol. .

Abstract

We utilized the well-validated University of Pennsylvania Smell Identification Test (UPSIT) to examine whether olfactory dysfunction occurs in ALS participants. After adjusting for relevant confounders in a multiple linear regression model, ALS participants scored significantly lower on the UPSIT compared with control participants, with an estimated mean difference of 2.31 points (P = 0.015). ALS participants also had twice the rate of olfactory dysfunction (microsmia or anosmia). This study suggests that olfactory dysfunction exists in ALS patients, which expands our understanding of the extramotor findings in ALS. Future investigations could determine whether there are correlations between olfactory dysfunction and specific ALS phenotypes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Olfactory dysfunction in ALS and control participants. (A) UPSIT scores in ALS participants. (B) UPSIT scores in control participants. (C) 43.59% of ALS participants have olfactory dysfunction—33.33% had microsmia, and 10.26% total smell loss (anosmia). Conversely, 21.74% of controls had olfactory dysfunction—21.74% had microsmia, and none had anosmia. P = 0.003.

References

    1. Ringholz GM, Appel SH, Bradshaw M, et al. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 2005;65:586–590. 10.1212/01.wnl.0000172911.39167.b6. - DOI - PubMed
    1. Elamin M, Phukan J, Bede P, et al. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology 2011;76:1263–1269. 10.1212/WNL.0b013e318214359f. - DOI - PubMed
    1. Orasji SS, Mulder JL, de Bruijn SF, Wirtz PW. Olfactory dysfunction in behavioral variant frontotemporal dementia. Clin Neurol Neurosurg 2016;141:106–110. 10.1016/j.clineuro.2016.01.003. - DOI - PubMed
    1. Mesholam RI, Moberg PJ, Mahr RN, Doty RL. Olfaction in neurodegenerative disease: a meta‐analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol 1998;55:84–90. - PubMed
    1. Ross GW, Petrovitch H, Abbott RD, et al. Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol 2008;63:167–173. 10.1002/ana.21291. - DOI - PubMed

LinkOut - more resources